ArticleFrontiers in cardiovascular medicine2023

Five-year cardiovascular outcomes in patients with chronic myeloid leukemia treated with imatinib, dasatinib, or nilotinib: A cohort study using data from a large multinational collaborative network.

Rafael Amorim Belo Nunes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.